Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Genomma Lab Internacional SAB de CV

Latest From Eli Lilly & Co.

China Expects Earlier Start Of National Marketing Authorization Holder System

After one year of testing the waters, China’s Drug Marketing Authorization Holder system is likely to have an earlier than expected start to the launch of final law amendment procedures, since the pilot scheme has significantly reduced investment duplication and encouraged pharma companies to file more innovative drug applications.

China Policy

Merck's Lantus Copy Lusduna Poised For US Market Pending Litigation

The Merck and Samsung Bioepis formulation of Sanofi's insulin glargine was tentatively approved by FDA, a designation that permits the drug to enter the market pending the resolution of ongoing patent litigation.

Biosimilars Approvals

Radius's Tymlos Dawdles At CHMP, No EU Opinion Yet

Radius Health has a new CEO, but the company's path to the EU market for its novel osteoporosis therapy Tymlos looks still subject to questions at this week's meeting of the European Medicines Agency’s CHMP.

Companies Regulation

Twitter Promo Study Gets Tweaks, But FDA Rejects Many Industry Suggestions

Lilly recommended testing use of embedded Twitter cards to convey safety information and PhRMA proposed studying a universal graphic symbol or FDA's logo.

Advertising, Marketing & Sales FDA
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • Mexico
  • Parent & Subsidiaries
  • Genomma Lab Internacional SAB de CV
  • Senior Management
  • Rodrigo Herrera Aspra, Chmn. & CEO
    Oscar Villalobos, VP, CFO
    Renata Herrera Aspra , Res., Dev. & Quality Dir.
    Luis Gerardo Cortés Moreno , Commercial Dir.
  • Contact Info
  • Genomma Lab Internacional SAB de CV
    Phone: 5081-0000
    Antonio Dovalí Jaime #70 Piso 2
    Obregón, 01210